Lifeboat Foundation

Ahead of its 2019 Build developer conference, Microsoft announced a slew of updates across its Azure cloud, cognitive services, blockchain, intelligent edge, and HoloLens 2.

CNBC flew to Fort Pickett with Under Secretary Ryan McCarthy to test the Army’s IVAS headset, which it’s building with Microsoft.

As the artificial brain races towards the singularity, what we often forget is the boost to human brainpower that will accompany it. As we increase our senses and perceptions, humans have a choice what to do with these new superpowers, that can be used to reinforce one’s tunnel vision of life or to ignore it.

This story is part of What Happens Next, our complete guide to understanding the future. Read more predictions about the Future of Fact.

Not everyone experiences the world in the same way. Whether it’s how you react to the results of an election or what tones you hear in a sound clip, observable reality is often not as objective as you think it is.

Emerging technologies such as augmented reality will further blur this line. With AR on mobile devices and head-mounted displays, we’re well within the start of what it means to live an augmented life. Humans are doing a lot of fun things right now, like integrating playful games into our world and painting ourselves with digitally applied effects and makeup. We’re also starting to find utility for AR in the workplace and with hardware designed specifically for the enterprise market.

Continue reading “VR and AR will expand the limits of human perception” »

The startup has an incredibly ambitious plan for the future.

But Microsoft still has a lot of work to do.

Prostate cancer remains one of the major causes of death worldwide. In view of the limited treatment options for patients with prostate cancer, preventive and treatment approaches based on natural compounds can play an integral role in tackling this disease. Recent evidence supports the beneficial effects of plant-derived phytochemicals as chemopreventive and chemotherapeutic agents for various cancers, including prostate cancer. Prunus africana has been used for generations in African traditional medicine to treat prostate cancer. This review examined the potential roles of the phytochemicals from P. africana, an endangered, sub-Saharan Africa plant in the chemoprevention and chemotherapy of prostate cancer. In vitro and in vivo studies have provided strong pharmacological evidence for antiprostate cancer activities of P. africana-derived phytochemicals. Through synergistic interactions between different effective phytochemicals, P. africana extracts have been shown to exhibit very strong antiandrogenic and antiangiogenic activities and have the ability to kill tumor cells via apoptotic pathways, prevent the proliferation of prostate cancer cells, and alter the signaling pathways required for the maintenance of prostate cancer cells. However, further preclinical and clinical studies ought to be done to advance and eventually use these promising phytochemicals for the prevention and chemotherapy of human prostate cancer.

Prostate cancer is one of the most common nonskin cancers in men. It is caused by unregulated prostate cell division, which leads to abnormal growth, with the potential to spread to other parts of the body [1]. These neoplastic cells originate from highly specialized cells through a process of regression to an advanced stage. Unlike the normal parent cells, these cells divide continuously, resulting in a tumor. Approximately, 9–11% of men are at risk of clinically suffering from prostate cancer in their life time [2–5]. Prostate cancer is typically androgen-dependent during its initial stages when the hormone androgen binds to the androgen receptor (AR) and then transactivates target genes [6, 7]. Androgen and AR-mediated signaling are therefore crucial for the development and functioning of both the normal prostate and prostate cancer.

The future is just over the horizon and we’re accelerating towards it. And while the famous Dr. Emmett Brown from Back to the Future once said, “Where we’re going, we don’t need roads,” at this year’s Consumer Electronics Show (CES), Nissan revealed not only the future of road-based transportation but equally your future whip.

Driving in the future will not only be autonomous, but will also seamlessly integrate the virtual world into your physical domain using mixed reality, creating an all-around intelligent, connected, transportation ecosystem.

Continue reading “Nissan Reveals Invisible Tech for a Visible Future at CES” »

Although it’s impossible (at least for now) to travel back in time to see the Big Bang, The New York Times has provided its readers the closest simulation of the experience via its latest augmented reality feature.

On Friday, the Times published “It’s Intermission for the Large Hadron Collider,” an interactive story that gives readers a virtual tour of the Large Hadron Collider at the European Center for Nuclear Research (CERN) in Switzerland and explores its most famous discovery, the Higgs boson.

Lockheed Martin engineers wear the goggles to help them assemble the crew capsule Orion—without having to read thousands of pages of paper instructions.